RET and cancer: Though not all RET alterations are clearly oncogenic, multiple aberrations with putative driving roles in tumorigenesis, such as TP53 truncating sequence variant and PIK3CA missence sequence variant, co-exist in most missence RET-aberrant cases with unknow significance, unmarking potential actionable oncogenic effects of those RET missence sequence variants on cancers.